Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients - Candlesense

CVKD Research

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

Published June 12, 2025 at 12:00 PM

PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #cadrenaltherapeutics--Cadrenal Therapeutics highlights new research on the economic and medical burden associated with oral anticoagulation for LVAD patients.